HomeNewsBusinessExclusive: Top funds write to govt for clarity on China FDI rule

Exclusive: Top funds write to govt for clarity on China FDI rule

Countries such as Spain, Germany, Australia, Italy have put curbs on FDI in their respective countries

April 27, 2020 / 21:16 IST
Story continues below Advertisement

India’s top private equity and venture capital funds - both foreign and domestic - are writing to the government seeking clarity on its decision to put FDI investments from China under approval, said three people directly aware of the matter, requesting anonymity as the talks are private.

These funds are being represented by the industry body Indian Venture Capital and Private Equity Association (IVCA), which is drafting the document along with law firm Khaitan & Co. They will reach out to the government in the coming week.

Story continues below Advertisement

While Khaitan confirmed the development, IVCA declined to comment

The VC and PE industry has been rocked by uncertainty, after the government's press note issued last week, became enforceable by law days later, saying that foreign direct investments from India’s neighbouring countries will be subject to approval. While China was not named, it was clearly the note’s target.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show